Andrew Barber

Jun 1, 2024 | onlinelibrary.wiley.com | Daniel Hinds |Rebekah J. Nevel |Deborah R. Liptzin |Andrew Barber

1 CHILD An important aspect of children's interstitial lung disease (chILD) is clear and concise classification of the diseases that enhance provider education and diagnostic abilities. Nathan et al.1 describe the European approach to diagnosing chILD, including descriptions of the most likely disease based on clinical histories, histopathology findings, radiographic findings, bronchoalveolar lavage results, genetic testing, and other “biological investigations” (i.e., lab testing).

Jul 26, 2023 | onlinelibrary.wiley.com | Andrew Barber |Deborah R. Liptzin |William A. Gower |Daniel Hinds

The field of rare and diffuse pediatric lung disease continues to evolve and expand rapidly as clinicians and researchers make advancements in the diagnosis and treatment of children's interstitial and diffuse lung disease, non-cystic fibrosis bronchiectasis, and primary ciliary dyskinesia.